USPTO trademark

EMYRA

AllowedUSPTOWord markClass 42

"EMYRA" is a word mark owned by Sherpa Rx, Inc., filed at the USPTO on August 1, 2025. It has been allowed and covers class 42 (Computer and Scientific Services).

Get this data via the API
Official USPTO record
EMYRA trademark as filed
As filed with the USPTO
Status
Allowed
Since July 14, 2026
Filed
August 1, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99315665
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns EMYRA

The owner and representative on file with the office.

Owner

Sherpa Rx, Inc.

Nashville, United States

Representative

Lucas R. Yordy

Goods and services

What the mark covers

The products and services EMYRA is filed for, grouped by Nice class.

  • Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing genetic test results, predicting how patients will metabolize drugs, and tailoring patient treatment plans based on patient genetics to improve efficacy and minimize side effects; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for tailoring patient treatment plans; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing genetic test results to optimize drug therapy; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for accessing and analyzing clinical guidelines, drug label annotations, and FDA drug label data to inform treatment plans; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing DNA test results to ensure optimal drug selection and dosing; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for integration with electronic health record systems of medical providers; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing gene-drug, drug-drug, food-drug interactions and nutrigenomics data to optimize drug therapy and nutrition plans; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing current and proposed patient treatment plans to identify known interactions between drugs that could lead to reduced effectiveness or adverse reactions; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing current and proposed patient treatment plans to identify dietary elements that may interfere with how medications are absorbed or metabolized; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing patient genetic test results related to nutrient metabolism and generating personalized dietary guidance to optimize health and support medication regimens

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Noa e-mailed - sou required from applicant
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Approved for pub - principal register
  6. Teas/email correspondence entered
  7. Correspondence received in law office
  8. Teas response to office action received
  9. Notification of non-final action e-mailed
  10. Non-final action e-mailed

5 earlier steps on the official record.

FAQ

About EMYRA

Who owns the trademark "EMYRA"?

The USPTO trademark "EMYRA" (application 99315665) is owned by Sherpa Rx, Inc.

What is the status of "EMYRA"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull EMYRA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b06-35d0-70be-a8d5-31d1eb9d223c
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b06-35d0-70be-a8d5-31d1eb9d223c",
  "object": "trademark",
  "mark_text": "EMYRA",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99315665",
  "filing_date": "2025-08-01",
  "nice_classes": [
    42
  ],
  "owners": [
    {
      "name": "Sherpa Rx, Inc.",
      "entity_id": null
    }
  ]
}